世界の転移性結腸直腸がん治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Metastatic Colorectal Cancer Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z09210 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、転移性結腸直腸がん治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。転移性結腸直腸がん治療の種類別市場規模（手術、化学療法）、用途別市場規模（病院、診療所、がん研究センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・転移性結腸直腸がん治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Roche、Eli Lilly、Pfizer、Novartis、Amgen、Taiho Oncology、Genentech、EMD Serono、Suzhou Zelgen Biopharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：手術、化学療法 ・用途別分析2016年-2026年：病院、診療所、がん研究センター ・転移性結腸直腸がん治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・転移性結腸直腸がん治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・転移性結腸直腸がん治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・転移性結腸直腸がん治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・転移性結腸直腸がん治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Metastatic Colorectal Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Metastatic Colorectal Cancer Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Metastatic Colorectal Cancer Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Metastatic Colorectal Cancer Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Surgery
Chemotherapy

Market segment by Application, can be divided into
Hospitals
Clinics
Cancer Research Centers

Market segment by players, this report covers
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Metastatic Colorectal Cancer Treatment
1.2 Classification of Metastatic Colorectal Cancer Treatment by Type
1.2.1 Overview: Global Metastatic Colorectal Cancer Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type in 2020
1.2.3 Surgery
1.2.4 Chemotherapy
1.3 Global Metastatic Colorectal Cancer Treatment Market by Application
1.3.1 Overview: Global Metastatic Colorectal Cancer Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Global Metastatic Colorectal Cancer Treatment Market Size & Forecast
1.5 Global Metastatic Colorectal Cancer Treatment Market Size and Forecast by Region
1.5.1 Global Metastatic Colorectal Cancer Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Metastatic Colorectal Cancer Treatment Market Size by Region, (2016-2021)
1.5.3 North America Metastatic Colorectal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Metastatic Colorectal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Metastatic Colorectal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Metastatic Colorectal Cancer Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Metastatic Colorectal Cancer Treatment Market Drivers
1.6.2 Metastatic Colorectal Cancer Treatment Market Restraints
1.6.3 Metastatic Colorectal Cancer Treatment Trends Analysis
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Metastatic Colorectal Cancer Treatment Product and Solutions
2.1.4 Sanofi Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Metastatic Colorectal Cancer Treatment Product and Solutions
2.2.4 Roche Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Product and Solutions
2.3.4 Eli Lilly Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Metastatic Colorectal Cancer Treatment Product and Solutions
2.4.4 Pfizer Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Metastatic Colorectal Cancer Treatment Product and Solutions
2.5.4 Novartis Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Metastatic Colorectal Cancer Treatment Product and Solutions
2.6.4 Amgen Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Taiho Oncology
2.7.1 Taiho Oncology Details
2.7.2 Taiho Oncology Major Business
2.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Product and Solutions
2.7.4 Taiho Oncology Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Taiho Oncology Recent Developments and Future Plans
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business
2.8.3 Genentech Metastatic Colorectal Cancer Treatment Product and Solutions
2.8.4 Genentech Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Genentech Recent Developments and Future Plans
2.9 EMD Serono
2.9.1 EMD Serono Details
2.9.2 EMD Serono Major Business
2.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Product and Solutions
2.9.4 EMD Serono Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 EMD Serono Recent Developments and Future Plans
2.10 Suzhou Zelgen Biopharmaceuticals
2.10.1 Suzhou Zelgen Biopharmaceuticals Details
2.10.2 Suzhou Zelgen Biopharmaceuticals Major Business
2.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product and Solutions
2.10.4 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Metastatic Colorectal Cancer Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Metastatic Colorectal Cancer Treatment Players Market Share
3.2.2 Top 10 Metastatic Colorectal Cancer Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Metastatic Colorectal Cancer Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Metastatic Colorectal Cancer Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Metastatic Colorectal Cancer Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2016-2021)
5.2 Metastatic Colorectal Cancer Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2026)
6.2 North America Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2026)
6.3 North America Metastatic Colorectal Cancer Treatment Market Size by Country
6.3.1 North America Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2026)
6.3.2 United States Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2026)
7.2 Europe Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2026)
7.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Country
7.3.1 Europe Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2026)
7.3.2 Germany Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.3 France Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region
8.3.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Region (2016-2026)
8.3.2 China Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.5 India Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2026)
9.2 South America Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2026)
9.3 South America Metastatic Colorectal Cancer Treatment Market Size by Country
9.3.1 South America Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country
10.3.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Metastatic Colorectal Cancer Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Metastatic Colorectal Cancer Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Metastatic Colorectal Cancer Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Metastatic Colorectal Cancer Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Metastatic Colorectal Cancer Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Region (2021-2026)
Table 6. Sanofi Corporate Information, Head Office, and Major Competitors
Table 7. Sanofi Major Business
Table 8. Sanofi Metastatic Colorectal Cancer Treatment Product and Solutions
Table 9. Sanofi Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Metastatic Colorectal Cancer Treatment Product and Solutions
Table 13. Roche Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly Major Business
Table 16. Eli Lilly Metastatic Colorectal Cancer Treatment Product and Solutions
Table 17. Eli Lilly Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Metastatic Colorectal Cancer Treatment Product and Solutions
Table 21. Pfizer Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Major Business
Table 24. Novartis Metastatic Colorectal Cancer Treatment Product and Solutions
Table 25. Novartis Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Metastatic Colorectal Cancer Treatment Product and Solutions
Table 29. Amgen Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Taiho Oncology Corporate Information, Head Office, and Major Competitors
Table 31. Taiho Oncology Major Business
Table 32. Taiho Oncology Metastatic Colorectal Cancer Treatment Product and Solutions
Table 33. Taiho Oncology Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Genentech Corporate Information, Head Office, and Major Competitors
Table 35. Genentech Major Business
Table 36. Genentech Metastatic Colorectal Cancer Treatment Product and Solutions
Table 37. Genentech Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. EMD Serono Corporate Information, Head Office, and Major Competitors
Table 39. EMD Serono Major Business
Table 40. EMD Serono Metastatic Colorectal Cancer Treatment Product and Solutions
Table 41. EMD Serono Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Suzhou Zelgen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Suzhou Zelgen Biopharmaceuticals Major Business
Table 44. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product and Solutions
Table 45. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Metastatic Colorectal Cancer Treatment Revenue (USD Million) by Players (2019-2021)
Table 47. Global Metastatic Colorectal Cancer Treatment Revenue Share by Players (2019-2021)
Table 48. Breakdown of Metastatic Colorectal Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Metastatic Colorectal Cancer Treatment Players Head Office, Products and Services Provided
Table 50. Metastatic Colorectal Cancer Treatment Mergers & Acquisitions in the Past Five Years
Table 51. Metastatic Colorectal Cancer Treatment New Entrants and Expansion Plans
Table 52. Global Metastatic Colorectal Cancer Treatment Revenue (USD Million) by Type (2016-2021)
Table 53. Global Metastatic Colorectal Cancer Treatment Revenue Share by Type (2016-2021)
Table 54. Global Metastatic Colorectal Cancer Treatment Revenue Forecast by Type (2021-2026)
Table 55. Global Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2021)
Table 56. Global Metastatic Colorectal Cancer Treatment Revenue Forecast by Application (2021-2026)
Table 57. North America Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Metastatic Colorectal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Metastatic Colorectal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Metastatic Colorectal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Metastatic Colorectal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Metastatic Colorectal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Metastatic Colorectal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Metastatic Colorectal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Metastatic Colorectal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Metastatic Colorectal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Metastatic Colorectal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Metastatic Colorectal Cancer Treatment Picture
Figure 2. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type in 2020
Figure 3. Surgery
Figure 4. Chemotherapy
Figure 5. Metastatic Colorectal Cancer Treatment Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Cancer Research Centers Picture
Figure 9. Global Metastatic Colorectal Cancer Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Metastatic Colorectal Cancer Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Region in 2020
Figure 13. North America Metastatic Colorectal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Metastatic Colorectal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Metastatic Colorectal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Metastatic Colorectal Cancer Treatment Market Drivers
Figure 18. Metastatic Colorectal Cancer Treatment Market Restraints
Figure 19. Metastatic Colorectal Cancer Treatment Market Trends
Figure 20. Sanofi Recent Developments and Future Plans
Figure 21. Roche Recent Developments and Future Plans
Figure 22. Eli Lilly Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Amgen Recent Developments and Future Plans
Figure 26. Taiho Oncology Recent Developments and Future Plans
Figure 27. Genentech Recent Developments and Future Plans
Figure 28. EMD Serono Recent Developments and Future Plans
Figure 29. Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans
Figure 31. Global Metastatic Colorectal Cancer Treatment Revenue Share by Players in 2020
Figure 32. Metastatic Colorectal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Metastatic Colorectal Cancer Treatment Revenue Market Share in 2020
Figure 34. Global Top 10 Players Metastatic Colorectal Cancer Treatment Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Metastatic Colorectal Cancer Treatment Revenue Share by Type in 2020
Figure 37. Global Metastatic Colorectal Cancer Treatment Market Share Forecast by Type (2021-2026)
Figure 38. Global Metastatic Colorectal Cancer Treatment Revenue Share by Application in 2020
Figure 39. Global Metastatic Colorectal Cancer Treatment Market Share Forecast by Application (2021-2026)
Figure 40. North America Metastatic Colorectal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 41. North America Metastatic Colorectal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 42. North America Metastatic Colorectal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 43. United States Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Metastatic Colorectal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 47. Europe Metastatic Colorectal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 48. Europe Metastatic Colorectal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 49. Germany Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Metastatic Colorectal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Metastatic Colorectal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue Market Share by Region (2016-2026)
Figure 57. China Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Metastatic Colorectal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 64. South America Metastatic Colorectal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 65. South America Metastatic Colorectal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Metastatic Colorectal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Metastatic Colorectal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Metastatic Colorectal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source

---